ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Blood Pressure Disorders Drug Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-5U6054
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Blood Pressure Disorders Drug Market Insights Forecast to 2028
BUY CHAPTERS

Global Blood Pressure Disorders Drug Market Research Report 2024

Code: QYRE-Auto-5U6054
Report
January 2024
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
A1M Pharma AB
Acceleron Pharma Inc
Ache Laboratorios Farmaceuticos SA
Actelion Pharmaceuticals Ltd
Aerogen
Anavex Life Sciences Corp
AnGes
Arena Pharmaceuticals Inc
Ascendia Pharmaceuticals LLC
Ascendis Pharma A/S
AVEO Pharmaceuticals Inc
Bayer
Bial - Portela & Ca SA
Bioblue Technologies Inc
Biogen
Biolab Farmaceutica Ltda
BioRestorative Therapies Inc
Boryung Pharmaceutical Co Ltd
Bristol-Myers Squibb Co
Camurus AB
Capricor Therapeutics, Inc.
Celsion Corp
Celtaxsys Inc
Chiesi Farmaceutici SpA
Chong Kun Dang Pharmaceutical Corp
Chugai Pharmaceutical Co., Ltd.
CJ HealthCare Corp
Complexa Inc
Corion Biotech Srl

Blood Pressure Disorders Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Blood Pressure Disorders Drug Market

Blood Pressure Disorders Drug Market

Blood pressure disorder drug development technology and related units
The global Blood Pressure Disorders Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Blood Pressure Disorders Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Pressure Disorders Drug.

Report Scope

The Blood Pressure Disorders Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Blood Pressure Disorders Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Pressure Disorders Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Blood Pressure Disorders Drug Market Report

Report Metric Details
Report Name Blood Pressure Disorders Drug Market
CAGR 5%
Segment by Type
  • Diuretics
  • Angiotensin Converting Enzyme (ACE) Inhibitors
  • Angiotensin Receptor Blockers (ARBs)
  • Others
Segment by Application
  • Hypertension
  • Hypotension
  • Pulmonary Hypertension
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company A1M Pharma AB, Acceleron Pharma Inc, Ache Laboratorios Farmaceuticos SA, Actelion Pharmaceuticals Ltd, Aerogen Ltd, Anavex Life Sciences Corp, AnGes Inc, Arena Pharmaceuticals Inc, Ascendia Pharmaceuticals LLC, Ascendis Pharma A/S, AVEO Pharmaceuticals Inc, Bayer AG, Bial - Portela & Ca SA, Bioblue Technologies Inc, Biogen Inc, Biolab Farmaceutica Ltda, BioRestorative Therapies Inc, Boryung Pharmaceutical Co Ltd, Bristol-Myers Squibb Co, Camurus AB, Capricor Therapeutics Inc, Celsion Corp, Celtaxsys Inc, Chiesi Farmaceutici SpA, Chong Kun Dang Pharmaceutical Corp, Chugai Pharmaceutical Co Ltd, CJ HealthCare Corp, Complexa Inc, Corion Biotech Srl
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Blood Pressure Disorders Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Blood Pressure Disorders Drug Market report?

Ans: The main players in the Blood Pressure Disorders Drug Market are A1M Pharma AB, Acceleron Pharma Inc, Ache Laboratorios Farmaceuticos SA, Actelion Pharmaceuticals Ltd, Aerogen Ltd, Anavex Life Sciences Corp, AnGes Inc, Arena Pharmaceuticals Inc, Ascendia Pharmaceuticals LLC, Ascendis Pharma A/S, AVEO Pharmaceuticals Inc, Bayer AG, Bial - Portela & Ca SA, Bioblue Technologies Inc, Biogen Inc, Biolab Farmaceutica Ltda, BioRestorative Therapies Inc, Boryung Pharmaceutical Co Ltd, Bristol-Myers Squibb Co, Camurus AB, Capricor Therapeutics Inc, Celsion Corp, Celtaxsys Inc, Chiesi Farmaceutici SpA, Chong Kun Dang Pharmaceutical Corp, Chugai Pharmaceutical Co Ltd, CJ HealthCare Corp, Complexa Inc, Corion Biotech Srl

What are the Application segmentation covered in the Blood Pressure Disorders Drug Market report?

Ans: The Applications covered in the Blood Pressure Disorders Drug Market report are Hypertension, Hypotension, Pulmonary Hypertension

What are the Type segmentation covered in the Blood Pressure Disorders Drug Market report?

Ans: The Types covered in the Blood Pressure Disorders Drug Market report are Diuretics, Angiotensin Converting Enzyme (ACE) Inhibitors, Angiotensin Receptor Blockers (ARBs), Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Pressure Disorders Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Diuretics
1.2.3 Angiotensin Converting Enzyme (ACE) Inhibitors
1.2.4 Angiotensin Receptor Blockers (ARBs)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Blood Pressure Disorders Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hypertension
1.3.3 Hypotension
1.3.4 Pulmonary Hypertension
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blood Pressure Disorders Drug Market Perspective (2019-2030)
2.2 Blood Pressure Disorders Drug Growth Trends by Region
2.2.1 Global Blood Pressure Disorders Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Blood Pressure Disorders Drug Historic Market Size by Region (2019-2024)
2.2.3 Blood Pressure Disorders Drug Forecasted Market Size by Region (2025-2030)
2.3 Blood Pressure Disorders Drug Market Dynamics
2.3.1 Blood Pressure Disorders Drug Industry Trends
2.3.2 Blood Pressure Disorders Drug Market Drivers
2.3.3 Blood Pressure Disorders Drug Market Challenges
2.3.4 Blood Pressure Disorders Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Pressure Disorders Drug Players by Revenue
3.1.1 Global Top Blood Pressure Disorders Drug Players by Revenue (2019-2024)
3.1.2 Global Blood Pressure Disorders Drug Revenue Market Share by Players (2019-2024)
3.2 Global Blood Pressure Disorders Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Blood Pressure Disorders Drug Revenue
3.4 Global Blood Pressure Disorders Drug Market Concentration Ratio
3.4.1 Global Blood Pressure Disorders Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Pressure Disorders Drug Revenue in 2023
3.5 Blood Pressure Disorders Drug Key Players Head office and Area Served
3.6 Key Players Blood Pressure Disorders Drug Product Solution and Service
3.7 Date of Enter into Blood Pressure Disorders Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Pressure Disorders Drug Breakdown Data by Type
4.1 Global Blood Pressure Disorders Drug Historic Market Size by Type (2019-2024)
4.2 Global Blood Pressure Disorders Drug Forecasted Market Size by Type (2025-2030)
5 Blood Pressure Disorders Drug Breakdown Data by Application
5.1 Global Blood Pressure Disorders Drug Historic Market Size by Application (2019-2024)
5.2 Global Blood Pressure Disorders Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Blood Pressure Disorders Drug Market Size (2019-2030)
6.2 North America Blood Pressure Disorders Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Blood Pressure Disorders Drug Market Size by Country (2019-2024)
6.4 North America Blood Pressure Disorders Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blood Pressure Disorders Drug Market Size (2019-2030)
7.2 Europe Blood Pressure Disorders Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Blood Pressure Disorders Drug Market Size by Country (2019-2024)
7.4 Europe Blood Pressure Disorders Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blood Pressure Disorders Drug Market Size (2019-2030)
8.2 Asia-Pacific Blood Pressure Disorders Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Blood Pressure Disorders Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Blood Pressure Disorders Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Blood Pressure Disorders Drug Market Size (2019-2030)
9.2 Latin America Blood Pressure Disorders Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Blood Pressure Disorders Drug Market Size by Country (2019-2024)
9.4 Latin America Blood Pressure Disorders Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Pressure Disorders Drug Market Size (2019-2030)
10.2 Middle East & Africa Blood Pressure Disorders Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Blood Pressure Disorders Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Blood Pressure Disorders Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 A1M Pharma AB
11.1.1 A1M Pharma AB Company Detail
11.1.2 A1M Pharma AB Business Overview
11.1.3 A1M Pharma AB Blood Pressure Disorders Drug Introduction
11.1.4 A1M Pharma AB Revenue in Blood Pressure Disorders Drug Business (2019-2024)
11.1.5 A1M Pharma AB Recent Development
11.2 Acceleron Pharma Inc
11.2.1 Acceleron Pharma Inc Company Detail
11.2.2 Acceleron Pharma Inc Business Overview
11.2.3 Acceleron Pharma Inc Blood Pressure Disorders Drug Introduction
11.2.4 Acceleron Pharma Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024)
11.2.5 Acceleron Pharma Inc Recent Development
11.3 Ache Laboratorios Farmaceuticos SA
11.3.1 Ache Laboratorios Farmaceuticos SA Company Detail
11.3.2 Ache Laboratorios Farmaceuticos SA Business Overview
11.3.3 Ache Laboratorios Farmaceuticos SA Blood Pressure Disorders Drug Introduction
11.3.4 Ache Laboratorios Farmaceuticos SA Revenue in Blood Pressure Disorders Drug Business (2019-2024)
11.3.5 Ache Laboratorios Farmaceuticos SA Recent Development
11.4 Actelion Pharmaceuticals Ltd
11.4.1 Actelion Pharmaceuticals Ltd Company Detail
11.4.2 Actelion Pharmaceuticals Ltd Business Overview
11.4.3 Actelion Pharmaceuticals Ltd Blood Pressure Disorders Drug Introduction
11.4.4 Actelion Pharmaceuticals Ltd Revenue in Blood Pressure Disorders Drug Business (2019-2024)
11.4.5 Actelion Pharmaceuticals Ltd Recent Development
11.5 Aerogen Ltd
11.5.1 Aerogen Ltd Company Detail
11.5.2 Aerogen Ltd Business Overview
11.5.3 Aerogen Ltd Blood Pressure Disorders Drug Introduction
11.5.4 Aerogen Ltd Revenue in Blood Pressure Disorders Drug Business (2019-2024)
11.5.5 Aerogen Ltd Recent Development
11.6 Anavex Life Sciences Corp
11.6.1 Anavex Life Sciences Corp Company Detail
11.6.2 Anavex Life Sciences Corp Business Overview
11.6.3 Anavex Life Sciences Corp Blood Pressure Disorders Drug Introduction
11.6.4 Anavex Life Sciences Corp Revenue in Blood Pressure Disorders Drug Business (2019-2024)
11.6.5 Anavex Life Sciences Corp Recent Development
11.7 AnGes Inc
11.7.1 AnGes Inc Company Detail
11.7.2 AnGes Inc Business Overview
11.7.3 AnGes Inc Blood Pressure Disorders Drug Introduction
11.7.4 AnGes Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024)
11.7.5 AnGes Inc Recent Development
11.8 Arena Pharmaceuticals Inc
11.8.1 Arena Pharmaceuticals Inc Company Detail
11.8.2 Arena Pharmaceuticals Inc Business Overview
11.8.3 Arena Pharmaceuticals Inc Blood Pressure Disorders Drug Introduction
11.8.4 Arena Pharmaceuticals Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024)
11.8.5 Arena Pharmaceuticals Inc Recent Development
11.9 Ascendia Pharmaceuticals LLC
11.9.1 Ascendia Pharmaceuticals LLC Company Detail
11.9.2 Ascendia Pharmaceuticals LLC Business Overview
11.9.3 Ascendia Pharmaceuticals LLC Blood Pressure Disorders Drug Introduction
11.9.4 Ascendia Pharmaceuticals LLC Revenue in Blood Pressure Disorders Drug Business (2019-2024)
11.9.5 Ascendia Pharmaceuticals LLC Recent Development
11.10 Ascendis Pharma A/S
11.10.1 Ascendis Pharma A/S Company Detail
11.10.2 Ascendis Pharma A/S Business Overview
11.10.3 Ascendis Pharma A/S Blood Pressure Disorders Drug Introduction
11.10.4 Ascendis Pharma A/S Revenue in Blood Pressure Disorders Drug Business (2019-2024)
11.10.5 Ascendis Pharma A/S Recent Development
11.11 AVEO Pharmaceuticals Inc
11.11.1 AVEO Pharmaceuticals Inc Company Detail
11.11.2 AVEO Pharmaceuticals Inc Business Overview
11.11.3 AVEO Pharmaceuticals Inc Blood Pressure Disorders Drug Introduction
11.11.4 AVEO Pharmaceuticals Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024)
11.11.5 AVEO Pharmaceuticals Inc Recent Development
11.12 Bayer AG
11.12.1 Bayer AG Company Detail
11.12.2 Bayer AG Business Overview
11.12.3 Bayer AG Blood Pressure Disorders Drug Introduction
11.12.4 Bayer AG Revenue in Blood Pressure Disorders Drug Business (2019-2024)
11.12.5 Bayer AG Recent Development
11.13 Bial - Portela & Ca SA
11.13.1 Bial - Portela & Ca SA Company Detail
11.13.2 Bial - Portela & Ca SA Business Overview
11.13.3 Bial - Portela & Ca SA Blood Pressure Disorders Drug Introduction
11.13.4 Bial - Portela & Ca SA Revenue in Blood Pressure Disorders Drug Business (2019-2024)
11.13.5 Bial - Portela & Ca SA Recent Development
11.14 Bioblue Technologies Inc
11.14.1 Bioblue Technologies Inc Company Detail
11.14.2 Bioblue Technologies Inc Business Overview
11.14.3 Bioblue Technologies Inc Blood Pressure Disorders Drug Introduction
11.14.4 Bioblue Technologies Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024)
11.14.5 Bioblue Technologies Inc Recent Development
11.15 Biogen Inc
11.15.1 Biogen Inc Company Detail
11.15.2 Biogen Inc Business Overview
11.15.3 Biogen Inc Blood Pressure Disorders Drug Introduction
11.15.4 Biogen Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024)
11.15.5 Biogen Inc Recent Development
11.16 Biolab Farmaceutica Ltda
11.16.1 Biolab Farmaceutica Ltda Company Detail
11.16.2 Biolab Farmaceutica Ltda Business Overview
11.16.3 Biolab Farmaceutica Ltda Blood Pressure Disorders Drug Introduction
11.16.4 Biolab Farmaceutica Ltda Revenue in Blood Pressure Disorders Drug Business (2019-2024)
11.16.5 Biolab Farmaceutica Ltda Recent Development
11.17 BioRestorative Therapies Inc
11.17.1 BioRestorative Therapies Inc Company Detail
11.17.2 BioRestorative Therapies Inc Business Overview
11.17.3 BioRestorative Therapies Inc Blood Pressure Disorders Drug Introduction
11.17.4 BioRestorative Therapies Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024)
11.17.5 BioRestorative Therapies Inc Recent Development
11.18 Boryung Pharmaceutical Co Ltd
11.18.1 Boryung Pharmaceutical Co Ltd Company Detail
11.18.2 Boryung Pharmaceutical Co Ltd Business Overview
11.18.3 Boryung Pharmaceutical Co Ltd Blood Pressure Disorders Drug Introduction
11.18.4 Boryung Pharmaceutical Co Ltd Revenue in Blood Pressure Disorders Drug Business (2019-2024)
11.18.5 Boryung Pharmaceutical Co Ltd Recent Development
11.19 Bristol-Myers Squibb Co
11.19.1 Bristol-Myers Squibb Co Company Detail
11.19.2 Bristol-Myers Squibb Co Business Overview
11.19.3 Bristol-Myers Squibb Co Blood Pressure Disorders Drug Introduction
11.19.4 Bristol-Myers Squibb Co Revenue in Blood Pressure Disorders Drug Business (2019-2024)
11.19.5 Bristol-Myers Squibb Co Recent Development
11.20 Camurus AB
11.20.1 Camurus AB Company Detail
11.20.2 Camurus AB Business Overview
11.20.3 Camurus AB Blood Pressure Disorders Drug Introduction
11.20.4 Camurus AB Revenue in Blood Pressure Disorders Drug Business (2019-2024)
11.20.5 Camurus AB Recent Development
11.21 Capricor Therapeutics Inc
11.21.1 Capricor Therapeutics Inc Company Detail
11.21.2 Capricor Therapeutics Inc Business Overview
11.21.3 Capricor Therapeutics Inc Blood Pressure Disorders Drug Introduction
11.21.4 Capricor Therapeutics Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024)
11.21.5 Capricor Therapeutics Inc Recent Development
11.22 Celsion Corp
11.22.1 Celsion Corp Company Detail
11.22.2 Celsion Corp Business Overview
11.22.3 Celsion Corp Blood Pressure Disorders Drug Introduction
11.22.4 Celsion Corp Revenue in Blood Pressure Disorders Drug Business (2019-2024)
11.22.5 Celsion Corp Recent Development
11.23 Celtaxsys Inc
11.23.1 Celtaxsys Inc Company Detail
11.23.2 Celtaxsys Inc Business Overview
11.23.3 Celtaxsys Inc Blood Pressure Disorders Drug Introduction
11.23.4 Celtaxsys Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024)
11.23.5 Celtaxsys Inc Recent Development
11.24 Chiesi Farmaceutici SpA
11.24.1 Chiesi Farmaceutici SpA Company Detail
11.24.2 Chiesi Farmaceutici SpA Business Overview
11.24.3 Chiesi Farmaceutici SpA Blood Pressure Disorders Drug Introduction
11.24.4 Chiesi Farmaceutici SpA Revenue in Blood Pressure Disorders Drug Business (2019-2024)
11.24.5 Chiesi Farmaceutici SpA Recent Development
11.25 Chong Kun Dang Pharmaceutical Corp
11.25.1 Chong Kun Dang Pharmaceutical Corp Company Detail
11.25.2 Chong Kun Dang Pharmaceutical Corp Business Overview
11.25.3 Chong Kun Dang Pharmaceutical Corp Blood Pressure Disorders Drug Introduction
11.25.4 Chong Kun Dang Pharmaceutical Corp Revenue in Blood Pressure Disorders Drug Business (2019-2024)
11.25.5 Chong Kun Dang Pharmaceutical Corp Recent Development
11.26 Chugai Pharmaceutical Co Ltd
11.26.1 Chugai Pharmaceutical Co Ltd Company Detail
11.26.2 Chugai Pharmaceutical Co Ltd Business Overview
11.26.3 Chugai Pharmaceutical Co Ltd Blood Pressure Disorders Drug Introduction
11.26.4 Chugai Pharmaceutical Co Ltd Revenue in Blood Pressure Disorders Drug Business (2019-2024)
11.26.5 Chugai Pharmaceutical Co Ltd Recent Development
11.27 CJ HealthCare Corp
11.27.1 CJ HealthCare Corp Company Detail
11.27.2 CJ HealthCare Corp Business Overview
11.27.3 CJ HealthCare Corp Blood Pressure Disorders Drug Introduction
11.27.4 CJ HealthCare Corp Revenue in Blood Pressure Disorders Drug Business (2019-2024)
11.27.5 CJ HealthCare Corp Recent Development
11.28 Complexa Inc
11.28.1 Complexa Inc Company Detail
11.28.2 Complexa Inc Business Overview
11.28.3 Complexa Inc Blood Pressure Disorders Drug Introduction
11.28.4 Complexa Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024)
11.28.5 Complexa Inc Recent Development
11.29 Corion Biotech Srl
11.29.1 Corion Biotech Srl Company Detail
11.29.2 Corion Biotech Srl Business Overview
11.29.3 Corion Biotech Srl Blood Pressure Disorders Drug Introduction
11.29.4 Corion Biotech Srl Revenue in Blood Pressure Disorders Drug Business (2019-2024)
11.29.5 Corion Biotech Srl Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
A1M Pharma AB
Acceleron Pharma Inc
Ache Laboratorios Farmaceuticos SA
Actelion Pharmaceuticals Ltd
Aerogen
Anavex Life Sciences Corp
AnGes
Arena Pharmaceuticals Inc
Ascendia Pharmaceuticals LLC
Ascendis Pharma A/S
AVEO Pharmaceuticals Inc
Bayer
Bial - Portela & Ca SA
Bioblue Technologies Inc
Biogen
Biolab Farmaceutica Ltda
BioRestorative Therapies Inc
Boryung Pharmaceutical Co Ltd
Bristol-Myers Squibb Co
Camurus AB
Capricor Therapeutics, Inc.
Celsion Corp
Celtaxsys Inc
Chiesi Farmaceutici SpA
Chong Kun Dang Pharmaceutical Corp
Chugai Pharmaceutical Co., Ltd.
CJ HealthCare Corp
Complexa Inc
Corion Biotech Srl
List of Tables
    Table 1. Global Blood Pressure Disorders Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Diuretics
    Table 3. Key Players of Angiotensin Converting Enzyme (ACE) Inhibitors
    Table 4. Key Players of Angiotensin Receptor Blockers (ARBs)
    Table 5. Key Players of Others
    Table 6. Global Blood Pressure Disorders Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Blood Pressure Disorders Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Blood Pressure Disorders Drug Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Blood Pressure Disorders Drug Market Share by Region (2019-2024)
    Table 10. Global Blood Pressure Disorders Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Blood Pressure Disorders Drug Market Share by Region (2025-2030)
    Table 12. Blood Pressure Disorders Drug Market Trends
    Table 13. Blood Pressure Disorders Drug Market Drivers
    Table 14. Blood Pressure Disorders Drug Market Challenges
    Table 15. Blood Pressure Disorders Drug Market Restraints
    Table 16. Global Blood Pressure Disorders Drug Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Blood Pressure Disorders Drug Market Share by Players (2019-2024)
    Table 18. Global Top Blood Pressure Disorders Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Pressure Disorders Drug as of 2023)
    Table 19. Ranking of Global Top Blood Pressure Disorders Drug Companies by Revenue (US$ Million) in 2023
    Table 20. Global 5 Largest Players Market Share by Blood Pressure Disorders Drug Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Blood Pressure Disorders Drug Product Solution and Service
    Table 23. Date of Enter into Blood Pressure Disorders Drug Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Blood Pressure Disorders Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Blood Pressure Disorders Drug Revenue Market Share by Type (2019-2024)
    Table 27. Global Blood Pressure Disorders Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Blood Pressure Disorders Drug Revenue Market Share by Type (2025-2030)
    Table 29. Global Blood Pressure Disorders Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Blood Pressure Disorders Drug Revenue Market Share by Application (2019-2024)
    Table 31. Global Blood Pressure Disorders Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Blood Pressure Disorders Drug Revenue Market Share by Application (2025-2030)
    Table 33. North America Blood Pressure Disorders Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 34. North America Blood Pressure Disorders Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 35. North America Blood Pressure Disorders Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 36. Europe Blood Pressure Disorders Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. Europe Blood Pressure Disorders Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 38. Europe Blood Pressure Disorders Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Asia-Pacific Blood Pressure Disorders Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 40. Asia-Pacific Blood Pressure Disorders Drug Market Size by Region (2019-2024) & (US$ Million)
    Table 41. Asia-Pacific Blood Pressure Disorders Drug Market Size by Region (2025-2030) & (US$ Million)
    Table 42. Latin America Blood Pressure Disorders Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Latin America Blood Pressure Disorders Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Blood Pressure Disorders Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Blood Pressure Disorders Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Middle East & Africa Blood Pressure Disorders Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Middle East & Africa Blood Pressure Disorders Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 48. A1M Pharma AB Company Detail
    Table 49. A1M Pharma AB Business Overview
    Table 50. A1M Pharma AB Blood Pressure Disorders Drug Product
    Table 51. A1M Pharma AB Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)
    Table 52. A1M Pharma AB Recent Development
    Table 53. Acceleron Pharma Inc Company Detail
    Table 54. Acceleron Pharma Inc Business Overview
    Table 55. Acceleron Pharma Inc Blood Pressure Disorders Drug Product
    Table 56. Acceleron Pharma Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)
    Table 57. Acceleron Pharma Inc Recent Development
    Table 58. Ache Laboratorios Farmaceuticos SA Company Detail
    Table 59. Ache Laboratorios Farmaceuticos SA Business Overview
    Table 60. Ache Laboratorios Farmaceuticos SA Blood Pressure Disorders Drug Product
    Table 61. Ache Laboratorios Farmaceuticos SA Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)
    Table 62. Ache Laboratorios Farmaceuticos SA Recent Development
    Table 63. Actelion Pharmaceuticals Ltd Company Detail
    Table 64. Actelion Pharmaceuticals Ltd Business Overview
    Table 65. Actelion Pharmaceuticals Ltd Blood Pressure Disorders Drug Product
    Table 66. Actelion Pharmaceuticals Ltd Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)
    Table 67. Actelion Pharmaceuticals Ltd Recent Development
    Table 68. Aerogen Ltd Company Detail
    Table 69. Aerogen Ltd Business Overview
    Table 70. Aerogen Ltd Blood Pressure Disorders Drug Product
    Table 71. Aerogen Ltd Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)
    Table 72. Aerogen Ltd Recent Development
    Table 73. Anavex Life Sciences Corp Company Detail
    Table 74. Anavex Life Sciences Corp Business Overview
    Table 75. Anavex Life Sciences Corp Blood Pressure Disorders Drug Product
    Table 76. Anavex Life Sciences Corp Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)
    Table 77. Anavex Life Sciences Corp Recent Development
    Table 78. AnGes Inc Company Detail
    Table 79. AnGes Inc Business Overview
    Table 80. AnGes Inc Blood Pressure Disorders Drug Product
    Table 81. AnGes Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)
    Table 82. AnGes Inc Recent Development
    Table 83. Arena Pharmaceuticals Inc Company Detail
    Table 84. Arena Pharmaceuticals Inc Business Overview
    Table 85. Arena Pharmaceuticals Inc Blood Pressure Disorders Drug Product
    Table 86. Arena Pharmaceuticals Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)
    Table 87. Arena Pharmaceuticals Inc Recent Development
    Table 88. Ascendia Pharmaceuticals LLC Company Detail
    Table 89. Ascendia Pharmaceuticals LLC Business Overview
    Table 90. Ascendia Pharmaceuticals LLC Blood Pressure Disorders Drug Product
    Table 91. Ascendia Pharmaceuticals LLC Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)
    Table 92. Ascendia Pharmaceuticals LLC Recent Development
    Table 93. Ascendis Pharma A/S Company Detail
    Table 94. Ascendis Pharma A/S Business Overview
    Table 95. Ascendis Pharma A/S Blood Pressure Disorders Drug Product
    Table 96. Ascendis Pharma A/S Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)
    Table 97. Ascendis Pharma A/S Recent Development
    Table 98. AVEO Pharmaceuticals Inc Company Detail
    Table 99. AVEO Pharmaceuticals Inc Business Overview
    Table 100. AVEO Pharmaceuticals Inc Blood Pressure Disorders Drug Product
    Table 101. AVEO Pharmaceuticals Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)
    Table 102. AVEO Pharmaceuticals Inc Recent Development
    Table 103. Bayer AG Company Detail
    Table 104. Bayer AG Business Overview
    Table 105. Bayer AG Blood Pressure Disorders Drug Product
    Table 106. Bayer AG Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)
    Table 107. Bayer AG Recent Development
    Table 108. Bial - Portela & Ca SA Company Detail
    Table 109. Bial - Portela & Ca SA Business Overview
    Table 110. Bial - Portela & Ca SA Blood Pressure Disorders Drug Product
    Table 111. Bial - Portela & Ca SA Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)
    Table 112. Bial - Portela & Ca SA Recent Development
    Table 113. Bioblue Technologies Inc Company Detail
    Table 114. Bioblue Technologies Inc Business Overview
    Table 115. Bioblue Technologies Inc Blood Pressure Disorders Drug Product
    Table 116. Bioblue Technologies Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)
    Table 117. Bioblue Technologies Inc Recent Development
    Table 118. Biogen Inc Company Detail
    Table 119. Biogen Inc Business Overview
    Table 120. Biogen Inc Blood Pressure Disorders Drug Product
    Table 121. Biogen Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)
    Table 122. Biogen Inc Recent Development
    Table 123. Biolab Farmaceutica Ltda Company Detail
    Table 124. Biolab Farmaceutica Ltda Business Overview
    Table 125. Biolab Farmaceutica Ltda Blood Pressure Disorders Drug Product
    Table 126. Biolab Farmaceutica Ltda Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)
    Table 127. Biolab Farmaceutica Ltda Recent Development
    Table 128. BioRestorative Therapies Inc Company Detail
    Table 129. BioRestorative Therapies Inc Business Overview
    Table 130. BioRestorative Therapies Inc Blood Pressure Disorders Drug Product
    Table 131. BioRestorative Therapies Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)
    Table 132. BioRestorative Therapies Inc Recent Development
    Table 133. Boryung Pharmaceutical Co Ltd Company Detail
    Table 134. Boryung Pharmaceutical Co Ltd Business Overview
    Table 135. Boryung Pharmaceutical Co Ltd Blood Pressure Disorders Drug Product
    Table 136. Boryung Pharmaceutical Co Ltd Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)
    Table 137. Boryung Pharmaceutical Co Ltd Recent Development
    Table 138. Bristol-Myers Squibb Co Company Detail
    Table 139. Bristol-Myers Squibb Co Business Overview
    Table 140. Bristol-Myers Squibb Co Blood Pressure Disorders Drug Product
    Table 141. Bristol-Myers Squibb Co Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)
    Table 142. Bristol-Myers Squibb Co Recent Development
    Table 143. Camurus AB Company Detail
    Table 144. Camurus AB Business Overview
    Table 145. Camurus AB Blood Pressure Disorders Drug Product
    Table 146. Camurus AB Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)
    Table 147. Camurus AB Recent Development
    Table 148. Capricor Therapeutics Inc Company Detail
    Table 149. Capricor Therapeutics Inc Business Overview
    Table 150. Capricor Therapeutics Inc Blood Pressure Disorders Drug Product
    Table 151. Capricor Therapeutics Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)
    Table 152. Capricor Therapeutics Inc Recent Development
    Table 153. Celsion Corp Company Detail
    Table 154. Celsion Corp Business Overview
    Table 155. Celsion Corp Blood Pressure Disorders Drug Product
    Table 156. Celsion Corp Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)
    Table 157. Celsion Corp Recent Development
    Table 158. Celtaxsys Inc Company Detail
    Table 159. Celtaxsys Inc Business Overview
    Table 160. Celtaxsys Inc Blood Pressure Disorders Drug Product
    Table 161. Celtaxsys Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)
    Table 162. Celtaxsys Inc Recent Development
    Table 163. Chiesi Farmaceutici SpA Company Detail
    Table 164. Chiesi Farmaceutici SpA Business Overview
    Table 165. Chiesi Farmaceutici SpA Blood Pressure Disorders Drug Product
    Table 166. Chiesi Farmaceutici SpA Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)
    Table 167. Chiesi Farmaceutici SpA Recent Development
    Table 168. Chong Kun Dang Pharmaceutical Corp Company Detail
    Table 169. Chong Kun Dang Pharmaceutical Corp Business Overview
    Table 170. Chong Kun Dang Pharmaceutical Corp Blood Pressure Disorders Drug Product
    Table 171. Chong Kun Dang Pharmaceutical Corp Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)
    Table 172. Chong Kun Dang Pharmaceutical Corp Recent Development
    Table 173. Chugai Pharmaceutical Co Ltd Company Detail
    Table 174. Chugai Pharmaceutical Co Ltd Business Overview
    Table 175. Chugai Pharmaceutical Co Ltd Blood Pressure Disorders Drug Product
    Table 176. Chugai Pharmaceutical Co Ltd Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)
    Table 177. Chugai Pharmaceutical Co Ltd Recent Development
    Table 178. CJ HealthCare Corp Company Detail
    Table 179. CJ HealthCare Corp Business Overview
    Table 180. CJ HealthCare Corp Blood Pressure Disorders Drug Product
    Table 181. CJ HealthCare Corp Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)
    Table 182. CJ HealthCare Corp Recent Development
    Table 183. Complexa Inc Company Detail
    Table 184. Complexa Inc Business Overview
    Table 185. Complexa Inc Blood Pressure Disorders Drug Product
    Table 186. Complexa Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)
    Table 187. Complexa Inc Recent Development
    Table 188. Corion Biotech Srl Company Detail
    Table 189. Corion Biotech Srl Business Overview
    Table 190. Corion Biotech Srl Blood Pressure Disorders Drug Product
    Table 191. Corion Biotech Srl Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)
    Table 192. Corion Biotech Srl Recent Development
    Table 193. Research Programs/Design for This Report
    Table 194. Key Data Information from Secondary Sources
    Table 195. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Blood Pressure Disorders Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Blood Pressure Disorders Drug Market Share by Type: 2023 VS 2030
    Figure 3. Diuretics Features
    Figure 4. Angiotensin Converting Enzyme (ACE) Inhibitors Features
    Figure 5. Angiotensin Receptor Blockers (ARBs) Features
    Figure 6. Others Features
    Figure 7. Global Blood Pressure Disorders Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Blood Pressure Disorders Drug Market Share by Application: 2023 VS 2030
    Figure 9. Hypertension Case Studies
    Figure 10. Hypotension Case Studies
    Figure 11. Pulmonary Hypertension Case Studies
    Figure 12. Blood Pressure Disorders Drug Report Years Considered
    Figure 13. Global Blood Pressure Disorders Drug Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Blood Pressure Disorders Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Blood Pressure Disorders Drug Market Share by Region: 2023 VS 2030
    Figure 16. Global Blood Pressure Disorders Drug Market Share by Players in 2023
    Figure 17. Global Top Blood Pressure Disorders Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Pressure Disorders Drug as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Blood Pressure Disorders Drug Revenue in 2023
    Figure 19. North America Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Blood Pressure Disorders Drug Market Share by Country (2019-2030)
    Figure 21. United States Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Blood Pressure Disorders Drug Market Share by Country (2019-2030)
    Figure 25. Germany Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. France Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. U.K. Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Italy Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Russia Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Nordic Countries Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Asia-Pacific Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific Blood Pressure Disorders Drug Market Share by Region (2019-2030)
    Figure 33. China Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Japan Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. South Korea Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Southeast Asia Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. India Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Australia Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Latin America Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America Blood Pressure Disorders Drug Market Share by Country (2019-2030)
    Figure 41. Mexico Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Brazil Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Middle East & Africa Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa Blood Pressure Disorders Drug Market Share by Country (2019-2030)
    Figure 45. Turkey Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Saudi Arabia Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. A1M Pharma AB Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)
    Figure 48. Acceleron Pharma Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)
    Figure 49. Ache Laboratorios Farmaceuticos SA Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)
    Figure 50. Actelion Pharmaceuticals Ltd Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)
    Figure 51. Aerogen Ltd Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)
    Figure 52. Anavex Life Sciences Corp Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)
    Figure 53. AnGes Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)
    Figure 54. Arena Pharmaceuticals Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)
    Figure 55. Ascendia Pharmaceuticals LLC Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)
    Figure 56. Ascendis Pharma A/S Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)
    Figure 57. AVEO Pharmaceuticals Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)
    Figure 58. Bayer AG Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)
    Figure 59. Bial - Portela & Ca SA Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)
    Figure 60. Bioblue Technologies Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)
    Figure 61. Biogen Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)
    Figure 62. Biolab Farmaceutica Ltda Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)
    Figure 63. BioRestorative Therapies Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)
    Figure 64. Boryung Pharmaceutical Co Ltd Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)
    Figure 65. Bristol-Myers Squibb Co Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)
    Figure 66. Camurus AB Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)
    Figure 67. Capricor Therapeutics Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)
    Figure 68. Celsion Corp Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)
    Figure 69. Celtaxsys Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)
    Figure 70. Chiesi Farmaceutici SpA Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)
    Figure 71. Chong Kun Dang Pharmaceutical Corp Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)
    Figure 72. Chugai Pharmaceutical Co Ltd Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)
    Figure 73. CJ HealthCare Corp Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)
    Figure 74. Complexa Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)
    Figure 75. Corion Biotech Srl Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Hemodynamic Altering Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-36L13936
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Heart Valve Repair Products - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-0F18702
Tue Oct 22 00:00:00 UTC 2024

Add to Cart

Severe Hypertriglyceridemia (SHTG) Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-3Y14261
Mon Oct 21 00:00:00 UTC 2024

Add to Cart

Ventricular Fibrillation Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-31Z14165
Thu Oct 17 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions